Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Active & Responsive
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for
Acute Ischemic Stroke
Location: Boston MA, Worcester MA, Bay Shore NY, New York NY,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18 - 70+
Code: NCT05611242
Phase3, Recruiting
Active & Responsive
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Treatment of Moderate to Severe Refractory Crohn's Disease
for
Crohns Disease
Location: New York NY, Gainesville FL, Cleveland OH, Ann Arbor MI,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18 - 65
Code: NCT06721962
Phase1, Phase2, Recruiting
Active & Responsive
52-week Open Label Safety-Tolerability Study
for
Schizophrenia
Location: New York NY, Philadelphia PA, Gaithersburg MD,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07369154
Phase3, Recruiting
Active & Responsive
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
for
Treatment-resistant Schizophrenia
Location: New York NY, Baltimore MD, Los Angeles CA
Sponsor: Newron Pharmaceuticals SPA
Sex: All
Age: 18+
Code: NCT07184619
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
for
Cancer-related Problem/Condition, Fatigue in Cancer Survivors,
Location: New York NY
Sponsor: 5 Point App, Inc.
Sex: All
Age: 18+
Code: NCT06754722
Recruiting
Active & Responsive
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
for
Chronic Hepatitis Delta
Location: New York NY, Baltimore MD, Louisville KY, La Jolla CA,
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 69
Code: NCT07096193
Phase1, Phase2, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase2, Recruiting
Active & Responsive
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Boston MA, The Bronx NY, Montreal, Syracuse NY, Toronto,
Sponsor: Alessandro Doria
Sex: All
Age: 18 - 70+
Code: NCT06217302
Phase3, Recruiting
Active & Responsive
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
for
Chronic Kidney Diseases, End Stage Renal Disease,
Location: Boston MA, Lake Success NY, Raleigh NC, Florence SC,
Sponsor: VenoStent
Sex: All
Age: 18+
Code: NCT06001827
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06911632
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Active & Responsive
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
for
Cystic Fibrosis
Location: Hawthorne NY, New York NY, Winston-Salem NC,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT05504837
Phase1, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,